Cellular Senescence Network (SenNet):Technology Projects (UG3/UH3 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH), including the Common Fund, National Institute on Aging, National Cancer Institute, and other participating NIH Institutes and Centers, plan to issue a Notice of Funding Opportunity for Stage 2 of the Cellular Senescence Network (SenNet) Program. This initiative aims to advance understanding of the biological effects of senescent cell heterogeneity on health and disease by identifying and characterizing tissue-specific senescence markers in human biospecimens. The goal is to support the development of senotherapeutic strategies that can improve health outcomes. A key component of this program is the Senescence Technology Projects (SenTecs), which will focus on creating innovative tools and technologies designed to address the complexity of senescence and enhance the ability to identify, characterize, and target senescent cell types in vivo. The upcoming funding opportunity will use the UG3/UH3 activity code, and applicants with expertise related to the impact of cellular senescence on human health, as well as skills in developing technologies or computational tools for senescent cell identification and characterization, are encouraged to consider submitting proposals. While applications are not currently being solicited, this advance notice is intended to give potential applicants time to form collaborations and design responsive projects. The program will not support clinical trials under this solicitation. Interested parties may contact Ajay Pillai at the NIH Office of Strategic Coordination for more information.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The NIH Common Fund, National Institute on Aging, National Cancer Institute and additional NIH Institutes and Centers (ICs) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Stage 2 of the Cellular Senescence Network (SenNet) Program, which seeks to understand the biological consequences of senescent cell heterogeneity in health and disease, identify and characterize tissue-specific senescence markers in human biospecimens to facilitate the development of senotherapeutic strategies that improve health outcomes. The program’s Senescence Technology Projects (SenTecs) will develop innovative tools and technologies that consider the complex nature of senescence to facilitate identification, characterization and targeting of senotypes in vivo. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UG3/UH3 activity code. Investigators with expertise and insights into the cellular senescence impact on human health, the development of technologies and computational tools to identify and characterize senescent cells and inform novel approaches for the strategic targeting of senescent cells in vivo are encouraged to apply in response to these new NOFOs.
